Considering that the outcomes of the IRE1α pathway in podocytes appear to be cytoprotective, and that multiple adaptive effects are mediated transcriptionally, selective activation of the ribonuclease domain of IRE1α could potentially promote proteostasis and reduce injury in glomerular disease (Cybulsky, 2017). The gene discussed is ERN1; the disease is glomerular disorder.